Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
I honestly think that the the RCGP and BAME group should take more proactive action regarding the rightful concerns regarding the deaths of certain sections of our community.
It is now well recognised that viral load is a factor (people working close to those with covid and densely populated communities including care homes). Co-morbidities of diabetes, ischaemic heart disease, chronic pulmonary conditions and kidney disease are all associated with poor outcomes. But in the ONS statistics at present time "Other co-morbidities" lie at 18 000 deaths. Other being not known.
A retrospective study run by the RCGP looking at these in detail may possible lead to an answer. I note for some reason that Hypertension and lipid lowering treatments are the forgotten co-morbidities in all studies and death certificates. Both of these have a high incidence in the BAME communities.
I don't believe the present administration will conduct the correct study that is needed. They have shown this by the latest report.
I am sure all GPs would be keen to help in a retrospective study of this group.
Re: Covid-19: Review of ethnic disparities is labelled “whitewash” for lack of recommendations
Dear Editor
I honestly think that the the RCGP and BAME group should take more proactive action regarding the rightful concerns regarding the deaths of certain sections of our community.
It is now well recognised that viral load is a factor (people working close to those with covid and densely populated communities including care homes). Co-morbidities of diabetes, ischaemic heart disease, chronic pulmonary conditions and kidney disease are all associated with poor outcomes. But in the ONS statistics at present time "Other co-morbidities" lie at 18 000 deaths. Other being not known.
A retrospective study run by the RCGP looking at these in detail may possible lead to an answer. I note for some reason that Hypertension and lipid lowering treatments are the forgotten co-morbidities in all studies and death certificates. Both of these have a high incidence in the BAME communities.
I don't believe the present administration will conduct the correct study that is needed. They have shown this by the latest report.
I am sure all GPs would be keen to help in a retrospective study of this group.
Competing interests: No competing interests